Medicare's ACCESS Model Pays for Healthcare AI Agents for the First Time
Medicare has launched ACCESS, a payment mechanism for medical AI agents. For the first time, the government pays for monitoring patients between visits, AI-placed phone calls, care coordination and medication reminders. Most of the tech community doesn't know about it, but it matters a great deal for healthtech.
AI-processed from TechCrunch; edited by Hamidun News
For the first time, the federal Medicare program has created a payment mechanism for AI agents in healthcare, and most of the tech world doesn't know it.
What ACCESS is
The new ACCESS payment model lets healthcare organizations use AI agents to monitor patients between visits. Until now, there was no government mechanism for funding such services. For the first time, Medicare pays for AI that:
- Monitors a patient's condition between doctor appointments
- Calls patients to check how they feel
- Coordinates care: housing, access to medication, social services
- Reminds patients to take medication and attend regular checkups
Each of these functions used to take a doctor's or nurse's time, or went undone altogether. Now there is a way to pay for them.
Why the tech world missed it
The change went almost unnoticed by most startups and venture investors. It wasn't announced loudly and didn't make the top AI news roundups. The reason is simple: it isn't a new GPT or an impressive robot. It's routine regulatory work, but this is exactly the kind of work that creates trillion-dollar markets.
Medicare is the largest payer in American medicine. When Medicare pays, doctors listen. When doctors pay, investment flows into companies.
What this changes for healthtech
For medical AI companies, this is a turning point. Selling an AI agent to a hospital used to be hard: vendors had to prove ROI, argue with administrators and wait for approvals. Now Medicare has said: we pay for this. Here is the price. That creates predictable demand.
Hospitals that used to answer "show me this cuts costs" now simply say: "Medicare covers it, let's deploy."
What it means
ACCESS is not a loud announcement about AI in medicine. It is a quiet embedding of AI into a government payment mechanism. But that is precisely what sets the conditions for AI agents to become an ordinary tool in hospitals, clinics and nursing homes.
For patients, it means better monitoring between visits; for doctors, a helper with routine tasks; for startups, a new, legal, government-funded market.
- Nov 1, 2026Local models lose to Opus and Codex: 0.21 on a MacBook versus 1.00 for Codex
- Nov 1, 2026Adobe's EditAgent judge picks a usable edit 81.3% of the time, versus 74.8% for EditScore
- Nov 1, 202616 models tested on 7 search tools: Exa averaged 10.5 out of 14, SearXNG about 3
- Nov 1, 2026Google's StreamVibe video agent beats other models by 10.7% on response timing and quality
Key Questions Answered
What ACCESS is?
The new ACCESS payment model lets healthcare organizations use AI agents to monitor patients between visits. Until now, there was no government mechanism for funding such services. For the first time, Medicare pays for AI that: Monitors a patient's condition between doctor appointments Calls patients to check how they feel Coordinates care: housing, access to medication, social services Reminds patients to take medication and attend regular checkups Each of these functions used to take a doctor's or nurse's time, or went undone altogether. Now there is a way to pay for them
Why the tech world missed it?
The change went almost unnoticed by most startups and venture investors. It wasn't announced loudly and didn't make the top AI news roundups. The reason is simple: it isn't a new GPT or an impressive robot. It's routine regulatory work, but this is exactly the kind of work that creates trillion-dollar markets. Medicare is the largest payer in American medicine. When Medicare pays, doctors listen. When doctors pay, investment flows into companies.
What this changes for healthtech?
For medical AI companies, this is a turning point. Selling an AI agent to a hospital used to be hard: vendors had to prove ROI, argue with administrators and wait for approvals. Now Medicare has said: we pay for this. Here is the price. That creates predictable demand. Hospitals that used to answer "show me this cuts costs" now simply say: "Medicare covers it, let's deploy."
Test Frontier LLMs & Autonomous Agents in One Workspace
Run Claude Opus 5.5, GPT-6, Gemini 3.1, and DeepSeek side-by-side in Nomad AI (nomadnet.ai) — unified model routing, deep research, and multimodal workflows under one subscription.
The AI world, distilled — once a week
Seven stories that actually mattered, hand-picked. No noise, no reposts, no press releases.
Done! Check your inbox for a confirmation.